SelectQuote Shares Soar 20.8% Amid DOJ Lawsuit Fallout and Morgan Stanley Stake
By ATTN Desk · Editorial oversight: Sean Han
Introduction
SELECTQUOTE INC (NYSE: SLQT) is a technology-enabled, direct-to-consumer insurance brokerage founded in 1985. The company provides price comparisons across life, auto, home, and Medicare products, assisting consumers in protecting their families, health, and property. As of the close on August 21, 2025, SLQT traded at USD 2.2101, up 20.77% on a volume of 192,661 shares.
| Ticker | Exchange | Price (08/21/2025) | Change (%) | Volume |
|---|---|---|---|---|
| SLQT | NYSE | 2.2101 | +20.77 | 192,661 |
Corporate Structure and Experience
Headquartered in Overland Park, Kansas, SELECTQUOTE employs between 1,001 and 5,000 people. The firm’s platform connects consumers with multiple highly rated insurance carriers, facilitating choice and transparency. In addition to its core brokerage services, SelectQuote operates SelectRx, a closed-door pharmacy launched in 2025 to support Medicare beneficiaries managing complex medication regimens.
Insurance Brokerage by Kieran
Recent Developments and News
- May 1, 2025: The U.S. Department of Justice filed a False Claims Act complaint alleging that insurers paid illegal kickbacks to brokers, including SelectQuote, for Medicare Advantage enrollments. Following the announcement, SLQT shares decreased by over 19%.
- August 5, 2025: Morgan Stanley reported beneficial ownership of 10,134,048 SLQT shares, representing 5.6% of outstanding stock, according to a Schedule 13G filing.
- August 21, 2025: SelectQuote filed a Form 8-K reporting material asset acquisitions under Item 2.02 and presenting quarterly financial results under Item 9.01.
Financial and Strategic Analysis
SELECTQUOTE’s model of unbiased comparison serves as a strategic cornerstone. The launch of SelectRx aims to enhance customer retention through improved medication adherence. Institutional investment by Morgan Stanley represents significant ownership in the company. Although detailed financial metrics were not disclosed in the August 21 filing, the changes in stock price and trading volume indicate active market engagement.
Market Position and Industry Context
In the U.S. insurance distribution sector, SELECTQUOTE competes with traditional brokers and digital marketplaces. Its direct-to-consumer approach and extensive carrier network differentiate it within a fragmented market. The allegations made in May 2025 about kickbacks highlight regulatory risks associated with the Medicare Advantage segment. By integrating insurance brokerage with pharmacy services, SelectQuote aligns with other insurtech companies pursuing comprehensive healthcare solutions.
tl;dr
A False Claims Act complaint filed on May 1, 2025, resulted in a decline of SLQT shares exceeding 19%. The stock rebounded by 20.77% as of August 21, 2025, with a trading volume of 192,661 shares. Morgan Stanley held a 5.6% stake in SLQT as of August 5, 2025. Recent filings include a Form 8-K on August 21, 2025, while the launch of SelectRx pharmacy services signifies ongoing strategic developments amid regulatory scrutiny.